AI assistant
Wendy's Co — Director's Dealing 2023
Feb 27, 2023
31695_dirs_2023-02-27_d1dd38d5-36e5-4264-8e9a-58b8f7fa2a4f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Wendy's Co (WEN)
CIK: 0000030697
Period of Report: 2023-02-16
Reporting Person: Ajmani Deepak (Chief Operations Officer - U.S)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 637 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) | $8.2225 | 2024-08-11 | Common Stock (27277) | Direct | |
| Employee Stock Option (Right to Buy) | $9.8575 | 2025-08-07 | Common Stock (31656) | Direct | |
| Employee Stock Option (Right to Buy) | $10.0875 | 2026-08-12 | Common Stock (27166) | Direct | |
| Employee Stock Option (Right to Buy) | $15.355 | 2027-08-11 | Common Stock (20003) | Direct | |
| Employee Stock Option (Right to Buy) | $18.515 | 2028-08-20 | Common Stock (15152) | Direct | |
| Employee Stock Option (Right to Buy) | $19.71 | 2029-08-09 | Common Stock (25707) | Direct | |
| Employee Stock Option (Right to Buy) | $22.34 | 2030-08-07 | Common Stock (14623) | Direct | |
| Employee Stock Option (Right to Buy) | $23.70 | 2031-08-13 | Common Stock (11055) | Direct | |
| Employee Stock Option (Right to Buy) | $21.40 | 2032-08-12 | Common Stock (14221) | Direct | |
| Restricted Stock Units | $0 | Common Stock (3791) | Direct |
Footnotes
F1: With tandem net exercise and tax withholding rights.
F2: The option vested in three equal installments on August 11, 2015, 2016 and 2017 and is currently exercisable as to all 27,277 shares.
F3: The option vested in three equal installments on August 7, 2016, 2017 and 2018 and is currently exercisable as to all 31,656 shares.
F4: The option vested in three equal installments on August 12, 2017, 2018 and 2019 and is currently exercisable as to all 27,166 shares.
F5: The option vested in three equal installments on August 11, 2018, 2019 and 2020 and is currently exercisable as to all 20,003 shares.
F6: The option vested in three equal installments on August 20, 2019, 2020 and 2021 and is currently exercisable as to all 15,152 shares.
F7: The option vested in three equal installments on August 9, 2020, 2021 and 2022 and is currently exercisable as to all 25,707 shares.
F8: The option became exercisable as to 4,874 shares on each of August 7, 2021 and 2022 and becomes exercisable as to 4,875 shares on August 7, 2023.
F9: The option became exercisable as to 3,685 shares on August 12, 2022 and becomes exercisable as to 3,685 shares on each of August 12, 2023 and 2024.
F10: The option becomes exercisable as to 4,740 shares on each of August 13, 2023 and 2024 and becomes exercisable as to 4,741 shares on August 13, 2025.
F11: With tandem dividend equivalent rights and tax withholding rights.
F12: The restricted stock units (161 of which represent dividend equivalent units) will vest on February 19, 2024, subject to Mr. Ajmani's continued employment with the Company on the vesting date.
F13: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.